121 related articles for article (PubMed ID: 36401550)
1. Removal of nonspecific binding proteins is required in co-immunoprecipitation with nuclear proteins.
Zeng X; Zeng WH; Zhou J; Liu XM; Huang G; Zhu H; Xiao S; Zeng Y; Cao D
Biotechniques; 2022 Dec; 73(6):289-296. PubMed ID: 36401550
[TBL] [Abstract][Full Text] [Related]
2. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
3. Identification of UHRF1/2 as new N-methylpurine DNA glycosylase-interacting proteins.
Liang C; Zhang X; Song S; Tian C; Yin Y; Xing G; He F; Zhang L
Biochem Biophys Res Commun; 2013 Apr; 433(4):415-9. PubMed ID: 23537643
[TBL] [Abstract][Full Text] [Related]
4. MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis.
Akaogi K; Ono W; Hayashi Y; Kishimoto H; Yanagisawa J
BMC Cancer; 2013 Feb; 13():65. PubMed ID: 23388179
[TBL] [Abstract][Full Text] [Related]
5. Erratum: Preparation of Poly(pentafluorophenyl acrylate) Functionalized SiO2 Beads for Protein Purification.
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31038480
[TBL] [Abstract][Full Text] [Related]
6. The p53 target protein Wig-1 binds hnRNP A2/B1 and RNA Helicase A via RNA.
Prahl M; Vilborg A; Palmberg C; Jörnvall H; Asker C; Wiman KG
FEBS Lett; 2008 Jun; 582(15):2173-7. PubMed ID: 18519039
[TBL] [Abstract][Full Text] [Related]
7. Effect of hydroxyurea on the promoter occupancy profiles of tumor suppressor p53 and p73.
Huang V; Lu X; Jiang Y; Wang JY
BMC Biol; 2009 Jun; 7():35. PubMed ID: 19558638
[TBL] [Abstract][Full Text] [Related]
8. G-actin guides p53 nuclear transport: potential contribution of monomeric actin in altered localization of mutant p53.
Saha T; Guha D; Manna A; Panda AK; Bhat J; Chatterjee S; Sa G
Sci Rep; 2016 Sep; 6():32626. PubMed ID: 27601274
[TBL] [Abstract][Full Text] [Related]
9. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo.
Kim EJ; Park JS; Um SJ
J Biol Chem; 2002 Aug; 277(35):32020-8. PubMed ID: 11925430
[TBL] [Abstract][Full Text] [Related]
11. Actin nucleation by a transcription co-factor that links cytoskeletal events with the p53 response.
Coutts AS; Weston L; La Thangue NB
Cell Cycle; 2010 Apr; 9(8):1511-5. PubMed ID: 20372063
[TBL] [Abstract][Full Text] [Related]
12. MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
Wang J; Zheng T; Chen X; Song X; Meng X; Bhatta N; Pan S; Jiang H; Liu L
J Gastroenterol Hepatol; 2011 Feb; 26(2):371-7. PubMed ID: 21261729
[TBL] [Abstract][Full Text] [Related]
13. A regulatory loop composed of RAP80-HDM2-p53 provides RAP80-enhanced p53 degradation by HDM2 in response to DNA damage.
Yan J; Menendez D; Yang XP; Resnick MA; Jetten AM
J Biol Chem; 2009 Jul; 284(29):19280-9. PubMed ID: 19433585
[TBL] [Abstract][Full Text] [Related]
14. p53 and p73: seeing double?
Soengas MS; Lowe SW
Nat Genet; 2000 Dec; 26(4):391-2. PubMed ID: 11101828
[No Abstract] [Full Text] [Related]
15. β-Actin facilitates etoposide-induced p53 nuclear import.
Qi W; Li J; Pei X; Ke Y; Bu Q; Ni X
J Biosci; 2020; 45():. PubMed ID: 32098913
[TBL] [Abstract][Full Text] [Related]
16. p53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by BAG-1.
Matsuzawa S; Takayama S; Froesch BA; Zapata JM; Reed JC
EMBO J; 1998 May; 17(10):2736-47. PubMed ID: 9582267
[TBL] [Abstract][Full Text] [Related]
17. Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters.
Saidj D; Cros MP; Hernandez-Vargas H; Guarino F; Sylla BS; Tommasino M; Accardi R
J Virol; 2013 Nov; 87(22):12139-50. PubMed ID: 24006445
[TBL] [Abstract][Full Text] [Related]
18. Co-Immunoprecipitation-Blotting: Analysis of Protein-Protein Interactions.
Tan L; Yammani RR
Methods Mol Biol; 2022; 2413():145-154. PubMed ID: 35044662
[TBL] [Abstract][Full Text] [Related]
19. Developmentally essential protein flightless I is a nuclear receptor coactivator with actin binding activity.
Lee YH; Campbell HD; Stallcup MR
Mol Cell Biol; 2004 Mar; 24(5):2103-17. PubMed ID: 14966289
[TBL] [Abstract][Full Text] [Related]
20. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
